GALA RENEE D — SEC insider filings
SEC reporting owner CIK 1607737. 34 insider filings on record with FilingPulse; latest filed 2026-11-05.
Transaction summary — filings shown
Covers all 34 filings on record, filed 2021-03-01 to 2026-11-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 13,635 shares, $2,396,304 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 36.
- Largest priced transaction: sale of 6,000 shares @ $131.75 ($790,474) in Jazz Pharmaceuticals plc, filed 2023-05-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | President & CEO, Director | 27 | — | 5 legs · 13,635 sh · $2,396,304 | 29 |
| DEXCOM INC (DXCM) | Director | 4 | — | — | 4 |
| Gossamer Bio, Inc. (GOSS) | Director | 3 | — | — | 3 |
Insider filings — GALA RENEE D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 1,000 @ $225.37 | EDGAR |
| 2026-10-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 2,000 @ $236.40 | EDGAR |
| 2026-09-10 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 1,967 @ $246.81 · Sale (S): 2,000 @ $243.03 | EDGAR |
| 2026-07-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 4,835 @ $237.72 | EDGAR |
| 2026-06-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Gift (G): 600 @ $0 | EDGAR |
| 2026-06-01 | 4 | DEXCOM INC (DXCM) | Grant/award (A): 5,605 @ $0 | EDGAR |
| 2026-03-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 7,065 @ $188.69 | EDGAR |
| 2026-03-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 44,465 @ $0 | EDGAR |
| 2026-01-21 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 12,741 @ $0 · Tax withholding (F): 5,371 @ $171.16 | EDGAR |
| 2025-12-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 80 @ $166.91 | EDGAR |
| 2025-08-11 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 18,808 @ $0 | EDGAR |
| 2025-07-07 | 4/A | DEXCOM INC (DXCM) | Grant/award (A): 1,161 @ $0 | EDGAR |
| 2025-05-12 | 4 | DEXCOM INC (DXCM) | Grant/award (A): 5,074 @ $0 | EDGAR |
| 2025-03-10 | 4 | DEXCOM INC (DXCM) | Grant/award (A): 5,720 @ $0 | EDGAR |
| 2025-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Disposition to issuer (D): 5,704 @ $138.95 | EDGAR |
| 2025-03-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 23,111 @ $0 · Grant/award (A): 11,555 @ $0 | EDGAR |
| 2025-01-22 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 7,741 @ $0 · Tax withholding (F): 3,300 @ $122.62 | EDGAR |
| 2024-12-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 80 @ $123.45 | EDGAR |
| 2024-04-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 1,736 @ $115.21 | EDGAR |
| 2024-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 3,622 @ $117.53 | EDGAR |
| 2024-03-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 19,916 @ $0 | EDGAR |
| 2024-01-19 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 7,079 @ $0 · Tax withholding (F): 3,204 @ $119.13 | EDGAR |
| 2023-11-14 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 772 @ $0 | EDGAR |
| 2023-06-09 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2023-05-19 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 6,000 @ $131.75 | EDGAR |
| 2023-04-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 1,807 @ $145.78 | EDGAR |
| 2023-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 12,784 @ $0 · Tax withholding (F): 1,557 @ $142.78 | EDGAR |
| 2022-12-22 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 2,635 @ $160 | EDGAR |
| 2022-07-15 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-04-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 1,633 @ $162.88 | EDGAR |
| 2022-03-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 11,730 @ $0 · Disposition to issuer (D): 720 @ $153.96 | EDGAR |
| 2021-06-10 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 23,500 (derivative) @ $0 | EDGAR |
| 2021-04-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 1,515 @ $164.71 | EDGAR |
| 2021-03-01 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 10,115 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-25 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1607737 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs